These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 27903960)

  • 21. Toward a Preoperative Classification of Lymph Node Metastases in Patients with Small Intestinal Neuroendocrine Tumors in the Era of Intestinal-Sparing Surgery.
    Lardière-Deguelte S; de Mestier L; Appéré F; Vullierme MP; Zappa M; Hoeffel C; Noaves M; Brixi H; Hentic O; Ruszniewski P; Cadiot G; Panis Y; Kianmanesh R
    Neuroendocrinology; 2016; 103(5):552-9. PubMed ID: 26445315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastasis Prevalence and Survival of Patients with T1-2 Gastric Neuroendocrine Tumor Treated with Endoscopic Therapy and Surgery.
    Wang M; Cheng S; Zhu L; Xu T; Zhang J; Zhang Y; Ping J; Wang R
    Dig Dis Sci; 2022 Jul; 67(7):3228-3238. PubMed ID: 34272627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract.
    Gibson WE; Gonzalez RS; Cates JMM; Liu E; Shi C
    Hum Pathol; 2018 Sep; 79():109-115. PubMed ID: 29763717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgery of upper GI gastrointestinal stromal tumors: our experience, prognostic analysis.
    Kasetsermwiriya W; Nagai E; Nakata K; Nagayoshi Y; Shimizu S; Tanaka M
    Hepatogastroenterology; 2015; 62(137):87-92. PubMed ID: 25911874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
    Kuo EJ; Salem RR
    Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors influencing survival in small bowel neuroendocrine tumor with liver metastases.
    Manguso N; Nissen N; Hendifar A; Harit A; Mirocha J; Friedman M; Lipshutz HG; Amersi F
    J Surg Oncol; 2019 Nov; 120(6):926-931. PubMed ID: 31396982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of surgery and chemotherapy for stage IV small bowel adenocarcinoma: A population-based analysis using Surveillance, Epidemiology, and End Result Program database.
    Liu T; Wu Y; Jiang T
    Cancer Med; 2020 Sep; 9(18):6638-6645. PubMed ID: 32750232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical Treatment of NEN of Small Bowel: A Retrospective Analysis.
    Watzka FM; Fottner C; Miederer M; Weber MM; Schad A; Lang H; Musholt TJ
    World J Surg; 2016 Mar; 40(3):749-58. PubMed ID: 26822157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smaller tumor size is associated with poor survival in stage II colon cancer: An analysis of 7,719 patients in the SEER database.
    Huang B; Feng Y; Zhu L; Xu T; Huang L; Cai G
    Int J Surg; 2016 Sep; 33 Pt A():157-63. PubMed ID: 27491969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical Principles in the Management of Small Bowel Neuroendocrine Tumors.
    Gangi A; Anaya DA
    Curr Treat Options Oncol; 2020 Aug; 21(11):88. PubMed ID: 32862334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Revised staging classification improves outcome prediction for small intestinal neuroendocrine tumors.
    Kim MK; Warner RR; Roayaie S; Harpaz N; Ward SC; Itzkowitz S; Wisnivesky JP
    J Clin Oncol; 2013 Oct; 31(30):3776-81. PubMed ID: 24043726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Factors Associated With Progression for Advanced-Stage/G1 and G2 Small-Bowel Neuroendocrine Tumors After Multimodal Therapy: Experience From a Tertiary Referral Center.
    Khetan P; Oyewole F; Wolin E; Kim MK; Divino CM
    Pancreas; 2020 Apr; 49(4):509-513. PubMed ID: 32224719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine tumors of the small intestine causing a desmoplastic reaction of the mesentery are a more aggressive cohort.
    Bösch F; Bruewer K; D'Anastasi M; Ilhan H; Knoesel T; Pratschke S; Thomas M; Rentsch M; Guba M; Werner J; Angele MK
    Surgery; 2018 Nov; 164(5):1093-1099. PubMed ID: 30076029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small intestinal neuroendocrine tumors with liver metastases and resection of the primary: Prognostic factors for decision making.
    Bertani E; Falconi M; Grana C; Botteri E; Chiappa A; Misitano P; Spada F; Ravizza D; Bazolli B; Fazio N
    Int J Surg; 2015 Aug; 20():58-64. PubMed ID: 26074290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population-based assessment of the surgical management of locally advanced colorectal cancer.
    Govindarajan A; Coburn NG; Kiss A; Rabeneck L; Smith AJ; Law CH
    J Natl Cancer Inst; 2006 Oct; 98(20):1474-81. PubMed ID: 17047196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Factors and Survival Outcome in Patients with Chordoma in the United States: A Population-Based Analysis.
    Lee IJ; Lee RJ; Fahim DK
    World Neurosurg; 2017 Aug; 104():346-355. PubMed ID: 28457925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of Surgical Cytoreduction in Patients with Small Intestinal Neuroendocrine Tumors Metastatic to the Liver and Peritoneum.
    Gudmundsdottir H; Fogliati A; Grotz TE; Thiels CA; Warner SG; Smoot RL; Truty MJ; Kendrick ML; Nagorney DM; Halfdanarson TR; Cleary SP; Starlinger P
    Ann Surg Oncol; 2024 Aug; 31(8):5370-5376. PubMed ID: 38689169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of surgery for gastric cancer with distant metastases: a retrospective study from the SEER database.
    Chen J; Kong Y; Weng S; Dong C; Zhu L; Yang Z; Zhong J; Yuan Y
    Oncotarget; 2017 Jan; 8(3):4342-4351. PubMed ID: 28008147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptomatic presentation as a predictor of recurrence in gastroenteropancreatic neuroendocrine tumors: A single institution experience over 15 years.
    Baptiste GG; Postlewait LM; Ethun CG; Le N; McInnis MR; Russell MC; Winer JH; Kooby DA; Staley CA; Maithel SK; Cardona K
    J Surg Oncol; 2016 Aug; 114(2):163-9. PubMed ID: 27157897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.